Trials / Completed
CompletedNCT01045395
Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Our overall goal is to evaluate the safety and efficacy of consumption of two algae formulations compared to a placebo on: degree of severity of skin lesions, plasma lipid levels, as well as other health-related markers, in individuals with clinically diagnosed psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Corn starch | 90mg/d |
| DIETARY_SUPPLEMENT | Unique Marine Algae Concentrate (UMAC) | 90mg/d |
| DIETARY_SUPPLEMENT | Golden brown algae | 90mg/d |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-06-01
- Completion
- 2010-11-01
- First posted
- 2010-01-11
- Last updated
- 2011-03-16
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01045395. Inclusion in this directory is not an endorsement.